Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation
British Journal of General Practice · 2024
DOI: 10.3399/bjgp24x737517 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of General Practice, 2024. Verfasst von Cuiling Wei und 22 weiteren Autor:innen. Beteiligte Einrichtung: The University of Hong Kong. Hauptthemen laut MEDLINE: COVID-19, Multimorbidity, Primary Health Care, SARS-CoV-2.
Abstract (Originalsprache)
Background
Older adults with multimorbidity are at high risk of mortality following COVID-19 hospitalisation. However, the potential benefit of timely primary care follow-up on severe outcomes post-COVID-19 has not been well established.
Aim
To examine the effectiveness of attending general outpatient within 30 days after discharge from COVID-19 on 1-year survival among older adults aged ≥85 years, with multimorbidity.
Method
We emulated a target trial using a comprehensive public healthcare database in Hong Kong. The cloning-censoring-weighting technique was used to minimise immortal time bias and confounding bias by adjusting for demographics, hospitalisation duration and ICU admission, baseline chronic conditions, and medication history. The outcome included all-cause and cause-specific mortality.
Results
Of 6183 eligible COVID-19 survivors, the all-cause mortality rate following COVID-19 hospitalisation was lower in general out-patient clinics (GOPC) group compared to non-GOPC group (17.1 versus 42.8 deaths per 100 person-year). After adjustment, primary care consultations within 30 days after discharge were associated with a significantly greater 1-year survival (difference in 1-year survival: 11.2%, 95% CI = 8.1% to 14.4%). We also observed better survival from respiratory diseases in the GOPC group. In a sensitivity analysis for different grace period lengths, we found that the earlier participants had a GOPC visit after COVID-19 discharge, the better the survival.
Conclusion
Timely primary care consultations after discharge may improve survival following COVID-19 hospitalisation among older adults aged ≥85 years, with multimorbidity. Expanding primary care services and implementing follow-up mechanisms are crucial to support this vulnerable population’s recovery and well-being.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The University of Hong Kong.
- London School of Hygiene & Tropical Medicine.
- University of Hong Kong.
Zitieren
APA
Wei, C., Vincent, Yan, K. C., Maringe, C., Rachel, Chu, Y. K., Liu, W., Liu, B., Hu, Y., Zhou, L., Celine, Chui, S. L., Li, X., Eric, Wan, Y. F., Cheung, C. L., Esther, Chan, W. Y., William, …, & Lai, F. (2024). Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation. British Journal of General Practice. https://doi.org/10.3399/bjgp24x737517
Vancouver
Wei C, Vincent, Yan KC, Maringe C, Rachel, Chu YK, et al. Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation. British Journal of General Practice. 2024. doi:10.3399/bjgp24x737517
BibTeX
@article{Wei2024,
author = {Wei, Cuiling and Vincent and Yan, Ka Chun and Maringe, Camille and Rachel and Chu, Yui Ki and Liu, Wenlong and Liu, Boyan and Hu, Yuqi and Zhou, Lingyue and Celine and Chui, Sze Ling and Li, Xue and Eric and Wan, Yuk Fai and Cheung, Ching Lung and Esther and Chan, Wai Yin and William and Wong, Chi Wai and Ian and Wong, Chi Kei and Lai, Francisco},
title = {Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation},
journal = {British Journal of General Practice},
year = {2024},
doi = {10.3399/bjgp24x737517}
}
EUVIMED